Multi-dimensional rehabilitation assessment and rehabilitation intervention for polymyositis and dermatomyositis

Development of specific rehabilitation assessment tools and research of multi-dimensional rehabilitation assessment and rehabilitation intervention for several rare diseases——polymyositis and dermatomyositis

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076971

Enrollment

Unknown

Registered

2023-10-25

Start date

2023-11-01

Completion date

Unknown

Last updated

2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polymyositis and dermatomyositis

Interventions

Moderate intensity rehabilitation group:Perform 3-5 sessions of moderate intensity aerobic exercises per week

Moderate intensity rehabilitation group:Perform 2-3 sessions of moderate intensity resistance exercises per week

Moderate intensity rehabilitation group:Conduct 3-5 sessions of respiratory rehabilitation per week

Moderate intensity rehabilitation group:Conduct 3-5 sessions of swallowing rehabilitation per week

Low intensity rehabilitation group:Perform 3-5 sessions of low intensity aerobic exercises per week

Low intensity rehabilitation group:Perform 2-3 sessions of low intensity resistance exercises per week

Low intensity rehabilitation group:Conduct 2-3 sessions of respiratory rehabilitation per week

Low intensity rehabilitation group:Conduct 2-3 sessions of swallowing rehabilitation per week

Control group:Single session of muscle strength, swallowing, breathing, aerobic endurance rehabilitation guidance

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: a)Age =18 years; b) Meets the IIM diagnostic criteria recommended by the International Myopathy Collaborative Group; c) Plan to receive standardized treatment; d) Informed consent.

Exclusion criteria

Exclusion criteria: a) Patients with severe infections, end-stage tumors, cardiovascular diseases, hematological diseases, neurological diseases, etc. that cannot receive standardized treatment; b) Unable or unwilling to participate in rehabilitation interventions.

Design outcomes

Primary

Measure	Time frame
Muscle strength of shoulder flexion ; Muscle strength of hip flexor;	—

Secondary

Measure	Time frame
MMASA score; 6 min walking test;Diaphragm movement and diaphragmatic systolic thickness;	—

Countries

China

Contacts

Public ContactZHAO Xiaoyi

Peking Union Medical College Hospital

zhaoxy0909@sina.com+86 152 1068 2390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026